Clinical Trials and Research News Weekly Roundup | 9-16-2019 S1 E10

youtube roundup

Join us as we go over our top stories from the week:

Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for Mesothelioma.
FirstHealth Makes History Enrolling the First Patient in Immunotherapy Clinical Trial Addressing Cervical Cancer.
San Francisco-Based, Infectious Disease-Focused Vir Biotechnology Now Files for IPO.
Large Payer Cigna to Fully Cover Multi-Million Dollar Gene Therapies.
California’s Central Valley Center of German-Originated $28M Biotechnology Firm Investment.
UCLA Investigator Leads Small Clinical Trial that Actually Reverses Aging Process by 2.5 Years on Average.
Thomas Jefferson University-based Research: Clinical Trials Under Siege in America.
Genentech Reports Results From Phase 3 BLOCKSTONE Trial; Xofluza Reduces Flu Threat by 86% Following Exposure.
Center for Psychedelic Research Opens at Johns Hopkins Medicine.
Northwestern Medicine’s ‘Successful’ Immunotherapy and Autoimmune Disease Research Program to Shut its’ Doors.
Drug Makers Responding to Price Pressures and Start Dropping Insulin Costs.
Penn PACE: Medicine & Radiology Receive $8.9M & Build a Center of Excellence Dedicated to Opioid Use Disorder Researc...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee